Follow the Generate Biomedicines, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was disclosed on 3 September 2026 (Cession). Among the most active insiders: ARNOLD FRANCES. The full history is free.
10
Insider Decl.
n/a
Thresholds
€237,972
4 ops.
Buy Volume
€13,778
1 ops.
Sell Volume
52Σ signal
Buys €237,972€13,778 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.